Follicle Stimulating Hormone (FSH) Receptor Polymorphisms in In-Vitro Fertilization Cycles.

Completed

Conditions studied: Infertility

In brief

This study is being done to identify if certain sequences (patterns) of key genes (called polymorphisms) may predict a response to fertility medications. The investigators will also determine if the individual response to fertility medications affects pregnancy rates in in-vitro fertilization.

Key facts

Study ID

NCT01002885

Run by

University Reproductive Associates

People needed

75

Starts

2009-07-01

Expected to finish

2013-05-01

Last updated by the study team

2013-12-10

Who can join

Age: 18 and older, up to 35. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 100 women less than 35 years old at time of signing the Informed Consent Form.
• Day 3 FSH level less than or equal to 10 mIU/ml with an estradiol < 70 pg/ml
• Day 3 antral follicle count of greater than 10 follicles total.
• Couples who have male factor infertility, tubal factor infertility, and unexplained infertility.
• Exclusion Criteria patients who have:
• Endometriosis
• Polycystic ovarian syndrome

Where it is running

• University Reproductive Associates — Hasbrouck Heights, New Jersey, United States
• University Reproductive Associates — Hoboken, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.